Arkolith/Insider Trading/AQST/Form 4

Jung Cassie

Chief Operating OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)2K$2.54$6K296K
Mar 9, 2025Tax withholding(F)8K$2.65$21K298K
Mar 7, 2025Grant(A)80K—$0313K
Mar 7, 2025Tax withholding(F)7K$2.65$20K306K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2025Grant(A)40K—$040K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-004227) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML